Interestingly, all carcinoma in situ (CIS) lesions showed GLUT-1 overexpression regardless of their nuclear grade (low grade, intermediate grade, and high grade), but we did not observe overexpression in atypical and non-atypical hyperplasia. The gene discussed is SLC2A1; the disease is in situ carcinoma.